Europe PMCopen access
Modulating the gut microbiota to enhance immune checkpoint inhibitor efficacy in colorectal cancer: mechanisms, therapeutic strategies, and clinical perspectives
Circadian rhythm, Colorectal Cancer, Gut Microbiota, Immune Checkpoint Inhibitors, Microbiome-Targeted Therapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 120190
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.